Active — Not RecruitingNot Applicable

Virtual Reality on Balance of Parkinson's Disease

Spain50 participantsStarted 2025-02-05

Plain-language summary

This study, titled: Effectiveness of immersive virtual reality on balance in people with Parkinson's disease. Is a randomized clinical trial conducted at Zaragoza Parkinson's Association in Spain. It aims to evaluate the effectiveness of a immersive virtual reality program in enhancing balance for patients with Parkinson.s disease (PD). PD is a neurodegenerative disease that has a major impact on patients' balance and gait, affecting their quality of life. Physical rehabilitation is crucial for maintaining and improving balance, and immersive virtual reality promises to be an alternative for improving outcomes in patients with PD.

Who can participate

Age range55 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of PD confirmed by a neurologist * Age between 55 and 90 years * Hoehn \& Yahr Scale score of 1 to 4 * Cognitive level of 24 or higher on the Mini Mental Examination Test * Ability to stand upright without assistance Exclusion Criteria: * Visual or auditory impairments that could interfere with the perception of information or trigger dizziness or epilepsy * Musculoskeletal conditions that hinder or prevent the execution of exercises or the ability to maintain a standing position for at least 20 minutes * Psychiatric disorders such as moderate or severe depression diagnosed in the last year and impulse control disorders diagnosed in the last year * Score of 20 points on the Simulator Sickness Questionnaire (SSQ scale), indicating the presence of severe adverse symptoms

What they're measuring

Balance-Mini-Balance Systems Test (Mini-BESTest)

Timeframe: Balance will be assessed at three time points: pre-intervention (M0), the day post-intervention (M1), and 90 days post-intervention (M2).

Trial details

NCT IDNCT07274514

SponsorInstituto de Investigación Sanitaria Aragón

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05